Amedisys (AMED) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Miscellaneous, net: 1.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Miscellaneous, net: 1.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $300.3 million versus the consensus estimate of $299.26 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
